
Mount Sinai, USA
Amaia Lujambio
Her research focuses on how genetic and epigenetic alterations contribute to tumorigenesis, alter treatment response, and create vulnerabilities that may be targeted therapeutically. Furthermore, she is also interested in understanding the role of cellular senescence in liver cancer initiation.